Leaders’ Series 2017 with Nestlé: Food Safety: Room for improvement
Nestlé Health Science's John O'Brien gives us his insight and predictions for 2017...
List view / Grid view
Nestlé Health Science's John O'Brien gives us his insight and predictions for 2017...
7 November 2016 | By New Food
Nestlé Health Science has announced that it will make an equity investment of USD 145 million in US-based Aimmune Therapeutics, which corresponds to a 15% stake after completion of the transaction...
27 April 2016 | By Victoria White, Digital Content Producer
Barbara McCartney, Regional Business Head for the Nestlé Health Science Consumer Care Business in North America, talks to New Food about FODMAPs and Nestlé Health Science's new web resource, LowFODMAPCentral.com...